X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (46) 46
male (36) 36
gastroenterology & hepatology (35) 35
female (34) 34
middle aged (33) 33
liver transplantation (30) 30
transplantation (29) 29
adult (27) 27
index medicus (25) 25
aged (24) 24
liver (23) 23
surgery (20) 20
living donors (18) 18
hepatocellular carcinoma (17) 17
treatment outcome (16) 16
recurrence (14) 14
retrospective studies (14) 14
donation of organs, tissues, etc (13) 13
cirrhosis (12) 12
gastroenterology and hepatology (12) 12
survival (12) 12
analysis (10) 10
follow-up studies (10) 10
living donor liver transplantation (9) 9
risk factors (9) 9
young adult (9) 9
adolescent (8) 8
disease (8) 8
experience (8) 8
medicine & public health (8) 8
prognosis (8) 8
radiofrequency ablation (8) 8
recipients (8) 8
carcinoma, hepatocellular - therapy (7) 7
care and treatment (7) 7
gastroenterology (7) 7
health aspects (7) 7
liver neoplasms - therapy (7) 7
liver transplantation - adverse effects (7) 7
living donor (7) 7
proportional hazards models (7) 7
risk-factors (7) 7
ethanol injection (6) 6
impact (6) 6
liver neoplasms - mortality (6) 6
oncology (6) 6
surgical oncology (6) 6
time factors (6) 6
transplantation of organs, tissues, etc (6) 6
united-states (6) 6
carcinoma, hepatocellular - mortality (5) 5
graft (5) 5
hepatectomy (5) 5
hepatocellular-carcinoma (5) 5
immunology (5) 5
infection (5) 5
liver cancer (5) 5
liver neoplasms - surgery (5) 5
liver transplantation - methods (5) 5
resection (5) 5
single-center (5) 5
survival analysis (5) 5
survival rate (5) 5
transplants & implants (5) 5
abdominal surgery (4) 4
age factors (4) 4
aged, 80 and over (4) 4
biliary cirrhosis (4) 4
carcinoma, hepatocellular - complications (4) 4
carcinoma, hepatocellular - surgery (4) 4
cells (4) 4
child (4) 4
diagnosis (4) 4
donors (4) 4
electrocoagulation - methods (4) 4
hepatitis (4) 4
hepatitis c (4) 4
hepatology (4) 4
hepatoma (4) 4
incidence (4) 4
internal medicine (4) 4
japan (4) 4
liver - pathology (4) 4
liver cirrhosis (4) 4
liver diseases (4) 4
liver neoplasms - complications (4) 4
liver transplantation - immunology (4) 4
liver transplantation - mortality (4) 4
medical colleges (4) 4
medicine (4) 4
microwaves - therapeutic use (4) 4
multivariate analysis (4) 4
patients (4) 4
antigens (3) 3
antiviral agents - therapeutic use (3) 3
association (3) 3
biology (3) 3
biopsy (3) 3
carcinoma, hepatocellular - diagnosis (3) 3
carcinoma, hepatocellular - pathology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 05/2018, Volume 154, Issue 6, pp. S-1098 - S-1099
Journal Article
BioMed Research International, ISSN 2314-6133, 2018, Volume 2018, pp. 5362810 - 8
Hepatorenal syndrome (HRS) decreases survival of cirrhotic patients. The outcomes of HRS after liver transplantation (LT) were inconsistently reported. We... 
Treatment Outcome | Liver Transplantation | Hepatorenal Syndrome - surgery | Humans | Middle Aged | Statistical analysis | Liver diseases | Kidneys | Transplants & implants | Liver | Mortality | Systematic review | Transplantation | Patients | Survival | Clinical outcomes | Graft rejection | Meta-analysis | Confidence intervals | Studies | Heterogeneity | Gastroenterology | Death | Liver transplantation
Journal Article
Transplantation, ISSN 0041-1337, 07/2018, Volume 102 Suppl 7S-1, pp. S248 - S248
BACKGROUNDAlthough a number of mobile applications for health promotion has been developed, the use of such tools in serious medical conditions is limited.... 
Journal Article
Gastroenterology, ISSN 0016-5085, 04/2017, Volume 152, Issue 5, pp. S1123 - S1123
Journal Article
Pediatric Transplantation, ISSN 1397-3142, 08/2018, Volume 22, Issue 5, pp. e13227 - n/a
Prophylactic measures are used to reduce DNHB after HBsAg‐negative patients receive anti‐HBc–positive liver grafts. This study investigated the incidence of... 
hepatitis B immunoglobulin | pediatric liver transplantation | de novo hepatitis B | hepatitis B vaccination | TRANSMISSION | VIRUS INFECTION | GRAFTS | PEDIATRICS | SURFACE-ANTIGEN | DONORS | CORE ANTIGEN | TRANSPLANTATION | Pediatrics | Hepatitis | Immunization | Hepatitis B surface antigen | Allografts | Syngeneic grafts | Vaccination | Prophylaxis | Seroconversion | Hepatitis B | Liver transplantation
Journal Article
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 10/2012, Volume 47, Issue 10, pp. 1152 - 1159
In Japan, sorafenib is now the first-line therapy for individuals with advanced hepatocellular carcinoma (HCC), but no other treatment is available for such... 
Time to progression | Survival analysis | Hepatocellular carcinoma | Systemic chemotherapy | LIVER-TRANSPLANTATION | ORAL ENILURACIL/5-FLUOROURACIL | ETHANOL INJECTION | RANDOMIZED CONTROLLED-TRIAL | FLUOROURACIL | SORAFENIB | CHEMOTHERAPY | PHASE-II TRIAL | CIRRHOSIS | GASTROENTEROLOGY & HEPATOLOGY | INTRAARTERIAL 5-FLUOROURACIL | Recombinant Proteins - therapeutic use | Carcinoma, Hepatocellular - mortality | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Polyethylene Glycols - adverse effects | Male | Recombinant Proteins - adverse effects | Liver Neoplasms - mortality | Polyethylene Glycols - therapeutic use | Antimetabolites, Antineoplastic - administration & dosage | Fluorouracil - therapeutic use | Carcinoma, Hepatocellular - drug therapy | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Injections, Subcutaneous | Aged, 80 and over | Adult | Female | Retrospective Studies | Antiviral Agents - therapeutic use | Japan | Interferon-alpha - therapeutic use | Liver Neoplasms - drug therapy | Survival Rate | Treatment Outcome | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Interferon-alpha - administration & dosage | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antiviral Agents - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Aged | Interferon-alpha - adverse effects | Infusions, Intravenous | Cohort Studies
Journal Article